Department of Medicine Sunderbyn Hospital
About Department of Medicine Sunderbyn Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Nordic Lymphoma Group
2
Nordic MDS Group
1
Clinical Trials at Department of Medicine Sunderbyn Hospital
During the past decade, Department of Medicine Sunderbyn Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Evaluation of Azacitidine in Transfusion Dependent Patients With Low-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)
2010-01-01
2012-08-01
Completed
30
Venetoclax, Lenalidomide and Rituximab in Patients With Relapsed/Refractory Mantle Cell Lymphoma
2018-07-01
2022-12-01
Active, not recruiting
59
Acalabrutinib and Rituximab in Elderly Patients With Untreated Mantle Cell Lymphoma
2021-12-15
2027-01-01
Recruiting
80
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Medicine Sunderbyn Hospital"
#1 collaborator was "AstraZeneca" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Department of Medicine Sunderbyn Hospital
According to Clinical.Site data, the most researched conditions in "Department of Medicine Sunderbyn Hospital" are
"Chronic Myelomonocytic Leukemia" (1 trials), "MCL" (1 trials), "Mantle Cell Lymphoma" (1 trials), "Myelodysplastic Syndrome" (1 trials) and "Relapsed Non Hodgkin Lymphoma" (1 trials). Many other conditions were trialed in "Department of Medicine Sunderbyn Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Department of Medicine Sunderbyn Hospital
Most popular intervention types in "Department of Medicine Sunderbyn Hospital" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma" (1 trials), "Azacitidine" (1 trials), "Erythropoetin" (1 trials) and "Venetoclax" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Department of Medicine Sunderbyn Hospital
The vast majority of trials in "Department of Medicine Sunderbyn Hospital" are
3 trials for "All" genders.
Clinical Trials Status at Department of Medicine Sunderbyn Hospital
Currently, there are NaN active trials in "Department of Medicine Sunderbyn Hospital".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Department of Medicine Sunderbyn Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Department of Medicine Sunderbyn Hospital, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".